HEADER    HORMONE/GROWTH FACTOR                   06-MAY-05   1ZLG              
TITLE     SOLUTION STRUCTURE OF THE EXTRACELLULAR MATRIX PROTEIN ANOSMIN-1      
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ANOSMIN 1;                                                 
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: KALLMANN SYNDROME PROTEIN, ADHESION MOLECULE-LIKE X-LINKED; 
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: KAL1, ADMLX, KAL, KALIG1;                                      
SOURCE   6 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER;                          
SOURCE   7 EXPRESSION_SYSTEM_COMMON: FRUIT FLY;                                 
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 7227;                                       
SOURCE   9 EXPRESSION_SYSTEM_STRAIN: SCHNEIDER 2 (S2) CELLS;                    
SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PMT/BIP/V5-HIS                            
KEYWDS    INSULIN-LIKE GROWTH FACTOR RECEPTOR CYS-RICH FOLD, WHEY ACIDIC        
KEYWDS   2 PROTEIN FOLD, FIBRONECTIN TYPE III FOLD, HORMONE-GROWTH FACTOR       
KEYWDS   3 COMPLEX                                                              
EXPDTA    SOLUTION SCATTERING                                                   
MDLTYP    CA ATOMS ONLY, CHAIN A                                                
AUTHOR    Y.HU,Z.SUN,J.T.EATON,P.M.BOULOUX,S.J.PERKINS                          
REVDAT   6   22-MAY-24 1ZLG    1       REMARK                                   
REVDAT   5   21-DEC-22 1ZLG    1       SEQADV                                   
REVDAT   4   11-OCT-17 1ZLG    1       REMARK                                   
REVDAT   3   07-APR-10 1ZLG    1       REMARK                                   
REVDAT   2   24-FEB-09 1ZLG    1       VERSN                                    
REVDAT   1   09-MAY-06 1ZLG    0                                                
JRNL        AUTH   Y.HU,Z.SUN,J.T.EATON,P.M.BOULOUX,S.J.PERKINS                 
JRNL        TITL   EXTENDED AND FLEXIBLE DOMAIN SOLUTION STRUCTURE OF THE       
JRNL        TITL 2 EXTRACELLULAR MATRIX PROTEIN ANOSMIN-1 BY X-RAY SCATTERING,  
JRNL        TITL 3 ANALYTICAL ULTRACENTRIFUGATION AND CONSTRAINED MODELLING.    
JRNL        REF    J.MOL.BIOL.                   V. 350   553 2005              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   15949815                                                     
JRNL        DOI    10.1016/J.JMB.2005.04.031                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : INSIGHTII 98                                         
REMARK   3   AUTHORS     :                                                      
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 680                                     
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 0                                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1ZLG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAY-05.                  
REMARK 100 THE DEPOSITION ID IS D_1000032856.                                   
REMARK 265                                                                      
REMARK 265 EXPERIMENTAL DETAILS                                                 
REMARK 265                                                                      
REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING                       
REMARK 265  DATA ACQUISITION                                                    
REMARK 265   RADIATION/NEUTRON SOURCE                 : ESRF BEAMLINE ID02      
REMARK 265   SYNCHROTRON (Y/N)                        : Y                       
REMARK 265   BEAMLINE TYPE                            : ID02                    
REMARK 265   BEAMLINE INSTRUMENT                      : NULL                    
REMARK 265   DETECTOR TYPE                            : FRELON CCD CAMERA       
REMARK 265   DETECTOR MANUFACTURER DETAILS            : NULL                    
REMARK 265   TEMPERATURE (KELVIN)                     : 288                     
REMARK 265   PH                                       : 7.4                     
REMARK 265   NUMBER OF TIME FRAMES USED               : 1                       
REMARK 265   PROTEIN CONCENTRATION RANGE (MG/ML)      : 0.2-0.4                 
REMARK 265   SAMPLE BUFFER                            : 12 MM NA PHOSPHATE,     
REMARK 265                                              220 MM NACL             
REMARK 265   DATA REDUCTION SOFTWARE                  : MULTICCD                
REMARK 265   GUINIER MEAN RADIUS OF GYRATION (NM)     : 6.65                    
REMARK 265   SIGMA MEAN RADIUS OF GYRATION            : 0.49                    
REMARK 265   R(XS-1) MEAN CROSS SECTIONAL RADII (NM)  : 1.88                    
REMARK 265   R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.77                    
REMARK 265   R(XS-2) MEAN CROSS SECTIONAL RADII (NM)  : NULL                    
REMARK 265   R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL                    
REMARK 265   P(R) PROTEIN LENGTH (NM)                 : 1                       
REMARK 265                                                                      
REMARK 265 DATA ANALYSIS AND MODEL FITTING:                                     
REMARK 265  METHOD USED TO DETERMINE THE STRUCTURE: CONSTRAINED SCATTERING      
REMARK 265                                          FITTING OF HOMOLOGY MODELS  
REMARK 265  SOFTWARE USED    : INSIGHT II, HOMOLOGY, DISCOVERY, BIOPOLYMER,     
REMARK 265                     DELPHI, O, SCTPL7, GNOM                          
REMARK 265  SOFTWARE AUTHORS : ACCELRYS                                         
REMARK 265  STARTING MODEL   : NULL                                             
REMARK 265                                                                      
REMARK 265 CONFORMERS, NUMBER CALCULATED   : 10000                              
REMARK 265 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 265 CONFORMERS, SELECTION CRITERIA  : THE MODELLED SCATTERING CURVES     
REMARK 265  WERE ASSESSED BY CALCULATION OF THE RG, RSX-1 AND VALUES IN THE     
REMARK 265  SAME Q RANGES USED IN THE EXPERIMENTAL GUINIER FITS. MODELS WERE    
REMARK 265  THEN RANKED USING A GOODNESS-OF-FIT R-FACTOR DEFINED BY ANALOGY     
REMARK 265  WITH PROTEIN CRYSTALLOGRAPHY                                        
REMARK 265                                                                      
REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 265                                                                      
REMARK 265  OTHER DETAILS: HOMOLOGY MODELS WERE BUILT FOR THE CYS-BOX, WAP      
REMARK 265  AND FOUR FNIII DOMAINS. THE POSITIONS OF THE DOMAINS WERE           
REMARK 265  DETERMINED BY AN APPROACH THAT COMBINED RANDOMISED LINKER           
REMARK 265  PEPTIDE STRUCTURES PRODUCED BY MOLECULAR DYNAMICS SIMULATIONS       
REMARK 265  WITH CURVE-FITTING TO EXPERIMENTAL X-RAY SOLUTION SCATTERING        
REMARK 265  DATA. A SINGLE ARRANGEMENT OF THE SIX DOMAINS IS PRESENTED,         
REMARK 265  WHICH IS REPRESENTATIVE OF A FAMILY OF STRUCTURES THAT FIT THE      
REMARK 265  SCATTERING DATA. MORE DETAILS ON THE MODELLING STRATEGY ARE         
REMARK 265  CONTAINED IN THE PRIMARY REFERENCE. THE ALGORITHM RESULTED IN       
REMARK 265  SEVERAL CLOSE APPROACHES BETWEEN ATOMS. THIS ENTRY CONTAINS FOUR    
REMARK 265  SUCH PAIRS ALA 292 - PRO 318 PRO 291 - GLU 319 PRO 27 - PHE 122     
REMARK 265  TYR 225 - PHE 355                                                   
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   CA   ALA A   292     CA   PRO A   318              0.40            
REMARK 500   CA   PRO A   291     CA   GLU A   319              0.84            
REMARK 500   CA   PRO A    27     CA   PHE A   122              0.87            
REMARK 500   CA   TYR A   225     CA   PHE A   355              1.52            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1IGR   RELATED DB: PDB                                   
REMARK 900 INSULIN-LIKE GROWTH FACTOR RECEPTOR                                  
REMARK 900 RELATED ID: 1FLE   RELATED DB: PDB                                   
REMARK 900 ELAFIN                                                               
REMARK 900 RELATED ID: 1FNA   RELATED DB: PDB                                   
REMARK 900 TENTH FNIII DOMAIN OF FIBRONECTIN                                    
DBREF  1ZLG A   24   680  UNP    P23352   KALM_HUMAN      24    680             
SEQADV 1ZLG ARG A   48  UNP  P23352    PRO    48 VARIANT                        
SEQADV 1ZLG GLY A  681  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG LYS A  682  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG PRO A  683  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG ILE A  684  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG PRO A  685  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG ASN A  686  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG PRO A  687  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG LEU A  688  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG LEU A  689  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG GLY A  690  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG LEU A  691  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG ASP A  692  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG SER A  693  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG THR A  694  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG ARG A  695  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG THR A  696  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG GLY A  697  UNP  P23352              CLONING ARTIFACT               
SEQADV 1ZLG HIS A  698  UNP  P23352              EXPRESSION TAG                 
SEQADV 1ZLG HIS A  699  UNP  P23352              EXPRESSION TAG                 
SEQADV 1ZLG HIS A  700  UNP  P23352              EXPRESSION TAG                 
SEQADV 1ZLG HIS A  701  UNP  P23352              EXPRESSION TAG                 
SEQADV 1ZLG HIS A  702  UNP  P23352              EXPRESSION TAG                 
SEQADV 1ZLG HIS A  703  UNP  P23352              EXPRESSION TAG                 
SEQRES   1 A  680  ALA ALA GLY PRO GLY ALA ALA ALA ALA ARG ARG LEU ASP          
SEQRES   2 A  680  GLU SER LEU SER ALA GLY SER VAL GLN ARG ALA ARG CYS          
SEQRES   3 A  680  ALA SER ARG CYS LEU SER LEU GLN ILE THR ARG ILE SER          
SEQRES   4 A  680  ALA PHE PHE GLN HIS PHE GLN ASN ASN GLY SER LEU VAL          
SEQRES   5 A  680  TRP CYS GLN ASN HIS LYS GLN CYS SER LYS CYS LEU GLU          
SEQRES   6 A  680  PRO CYS LYS GLU SER GLY ASP LEU ARG LYS HIS GLN CYS          
SEQRES   7 A  680  GLN SER PHE CYS GLU PRO LEU PHE PRO LYS LYS SER TYR          
SEQRES   8 A  680  GLU CYS LEU THR SER CYS GLU PHE LEU LYS TYR ILE LEU          
SEQRES   9 A  680  LEU VAL LYS GLN GLY ASP CYS PRO ALA PRO GLU LYS ALA          
SEQRES  10 A  680  SER GLY PHE ALA ALA ALA CYS VAL GLU SER CYS GLU VAL          
SEQRES  11 A  680  ASP ASN GLU CYS SER GLY VAL LYS LYS CYS CYS SER ASN          
SEQRES  12 A  680  GLY CYS GLY HIS THR CYS GLN VAL PRO LYS THR LEU TYR          
SEQRES  13 A  680  LYS GLY VAL PRO LEU LYS PRO ARG LYS GLU LEU ARG PHE          
SEQRES  14 A  680  THR GLU LEU GLN SER GLY GLN LEU GLU VAL LYS TRP SER          
SEQRES  15 A  680  SER LYS PHE ASN ILE SER ILE GLU PRO VAL ILE TYR VAL          
SEQRES  16 A  680  VAL GLN ARG ARG TRP ASN TYR GLY ILE HIS PRO SER GLU          
SEQRES  17 A  680  ASP ASP ALA THR HIS TRP GLN THR VAL ALA GLN THR THR          
SEQRES  18 A  680  ASP GLU ARG VAL GLN LEU THR ASP ILE ARG PRO SER ARG          
SEQRES  19 A  680  TRP TYR GLN PHE ARG VAL ALA ALA VAL ASN VAL HIS GLY          
SEQRES  20 A  680  THR ARG GLY PHE THR ALA PRO SER LYS HIS PHE ARG SER          
SEQRES  21 A  680  SER LYS ASP PRO SER ALA PRO PRO ALA PRO ALA ASN LEU          
SEQRES  22 A  680  ARG LEU ALA ASN SER THR VAL ASN SER ASP GLY SER VAL          
SEQRES  23 A  680  THR VAL THR ILE VAL TRP ASP LEU PRO GLU GLU PRO ASP          
SEQRES  24 A  680  ILE PRO VAL HIS HIS TYR LYS VAL PHE TRP SER TRP MET          
SEQRES  25 A  680  VAL SER SER LYS SER LEU VAL PRO THR LYS LYS LYS ARG          
SEQRES  26 A  680  ARG LYS THR THR ASP GLY PHE GLN ASN SER VAL ILE LEU          
SEQRES  27 A  680  GLU LYS LEU GLN PRO ASP CYS ASP TYR VAL VAL GLU LEU          
SEQRES  28 A  680  GLN ALA ILE THR TYR TRP GLY GLN THR ARG LEU LYS SER          
SEQRES  29 A  680  ALA LYS VAL SER LEU HIS PHE THR SER THR HIS ALA THR          
SEQRES  30 A  680  ASN ASN LYS GLU GLN LEU VAL LYS THR ARG LYS GLY GLY          
SEQRES  31 A  680  ILE GLN THR GLN LEU PRO PHE GLN ARG ARG ARG PRO THR          
SEQRES  32 A  680  ARG PRO LEU GLU VAL GLY ALA PRO PHE TYR GLN ASP GLY          
SEQRES  33 A  680  GLN LEU GLN VAL LYS VAL TYR TRP LYS LYS THR GLU ASP          
SEQRES  34 A  680  PRO THR VAL ASN ARG TYR HIS VAL ARG TRP PHE PRO GLU          
SEQRES  35 A  680  ALA CYS ALA HIS ASN ARG THR THR GLY SER GLU ALA SER          
SEQRES  36 A  680  SER GLY MET THR HIS GLU ASN TYR ILE ILE LEU GLN ASP          
SEQRES  37 A  680  LEU SER PHE SER CYS LYS TYR LYS VAL THR VAL GLN PRO          
SEQRES  38 A  680  ILE ARG PRO LYS SER HIS SER LYS ALA GLU ALA VAL PHE          
SEQRES  39 A  680  PHE THR THR PRO PRO CYS SER ALA LEU LYS GLY LYS SER          
SEQRES  40 A  680  HIS LYS PRO ILE GLY CYS LEU GLY GLU ALA GLY HIS VAL          
SEQRES  41 A  680  LEU SER LYS VAL LEU ALA LYS PRO GLU ASN LEU SER ALA          
SEQRES  42 A  680  SER PHE ILE VAL GLN ASP VAL ASN ILE THR GLY HIS PHE          
SEQRES  43 A  680  SER TRP LYS MET ALA LYS ALA ASN LEU TYR GLN PRO MET          
SEQRES  44 A  680  THR GLY PHE GLN VAL THR TRP ALA GLU VAL THR THR GLU          
SEQRES  45 A  680  SER ARG GLN ASN SER LEU PRO ASN SER ILE ILE SER GLN          
SEQRES  46 A  680  SER GLN ILE LEU PRO SER ASP HIS TYR VAL LEU THR VAL          
SEQRES  47 A  680  PRO ASN LEU ARG PRO SER THR LEU TYR ARG LEU GLU VAL          
SEQRES  48 A  680  GLN VAL LEU THR PRO GLY GLY GLU GLY PRO ALA THR ILE          
SEQRES  49 A  680  LYS THR PHE ARG THR PRO GLU LEU PRO PRO SER SER ALA          
SEQRES  50 A  680  HIS ARG SER HIS LEU LYS HIS ARG HIS PRO HIS HIS TYR          
SEQRES  51 A  680  LYS PRO SER PRO GLU ARG TYR GLY LYS PRO ILE PRO ASN          
SEQRES  52 A  680  PRO LEU LEU GLY LEU ASP SER THR ARG THR GLY HIS HIS          
SEQRES  53 A  680  HIS HIS HIS HIS                                              
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000